155 related articles for article (PubMed ID: 34684822)
1. Double-PEGylated Cyclopeptidic Photosensitizer Prodrug Improves Drug Uptake from In Vitro to Hen's Egg Chorioallantoic Membrane Model.
Bouilloux J; Kiening M; Yapi S; Lange N
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684822
[TBL] [Abstract][Full Text] [Related]
2. Cyclopeptidic photosensitizer prodrugs as proteolytically triggered drug delivery systems of pheophorbide A: part II - co-loading of pheophorbide A and black hole quencher.
Bouilloux J; Yushchenko O; Dereka B; Boso G; Babič A; Zbinden H; Vauthey E; Lange N
Photochem Photobiol Sci; 2018 Nov; 17(11):1739-1748. PubMed ID: 30215090
[TBL] [Abstract][Full Text] [Related]
3. Cyclopeptidic photosensitizer prodrugs as proteolytically triggered drug delivery systems of pheophorbide A: part I - self-quenched prodrugs.
Bouilloux J; Yushchenko O; Dereka B; Boso G; Zbinden H; Vauthey E; Babič A; Lange N
Photochem Photobiol Sci; 2018 Nov; 17(11):1728-1738. PubMed ID: 30215073
[TBL] [Abstract][Full Text] [Related]
4. Enhanced prostate cancer targeting by modified protease sensitive photosensitizer prodrugs.
Zuluaga MF; Gabriel D; Lange N
Mol Pharm; 2012 Jun; 9(6):1570-9. PubMed ID: 22548315
[TBL] [Abstract][Full Text] [Related]
5. Selective photodetection and photodynamic therapy for prostate cancer through targeting of proteolytic activity.
Zuluaga MF; Sekkat N; Gabriel D; van den Bergh H; Lange N
Mol Cancer Ther; 2013 Mar; 12(3):306-13. PubMed ID: 23270928
[TBL] [Abstract][Full Text] [Related]
6. Thrombin-sensitive photodynamic agents: a novel strategy for selective synovectomy in rheumatoid arthritis.
Gabriel D; Busso N; So A; van den Bergh H; Gurny R; Lange N
J Control Release; 2009 Sep; 138(3):225-34. PubMed ID: 19445983
[TBL] [Abstract][Full Text] [Related]
7. Activity of phosphatase-sensitive 5-aminolevulinic acid prodrugs in cancer cell lines.
Herceg V; Lange N; Allémann E; Babič A
J Photochem Photobiol B; 2017 Jun; 171():34-42. PubMed ID: 28472723
[TBL] [Abstract][Full Text] [Related]
8. Contrast-enhanced MRI-guided photodynamic cancer therapy with a pegylated bifunctional polymer conjugate.
Vaidya A; Sun Y; Feng Y; Emerson L; Jeong EK; Lu ZR
Pharm Res; 2008 Sep; 25(9):2002-11. PubMed ID: 18584312
[TBL] [Abstract][Full Text] [Related]
9. Pegylation of a chlorin(e6) polymer conjugate increases tumor targeting of photosensitizer.
Hamblin MR; Miller JL; Rizvi I; Ortel B; Maytin EV; Hasan T
Cancer Res; 2001 Oct; 61(19):7155-62. PubMed ID: 11585749
[TBL] [Abstract][Full Text] [Related]
10. Folate-mediated and pH-responsive chidamide-bound micelles encapsulating photosensitizers for tumor-targeting photodynamic therapy.
Ma Z; Hu P; Guo C; Wang D; Zhang X; Chen M; Wang Q; Sun M; Zeng P; Lu F; Sun L; She L; Zhang H; Yao J; Yang F
Int J Nanomedicine; 2019; 14():5527-5540. PubMed ID: 31413561
[No Abstract] [Full Text] [Related]
11. Squalene-PEG: Pyropheophorbide-a nanoconstructs for tumor theranostics.
Adriouach S; Vorobiev V; Trefalt G; Allémann E; Lange N; Babič A
Nanomedicine; 2019 Jan; 15(1):243-251. PubMed ID: 30304701
[TBL] [Abstract][Full Text] [Related]
12. Target-selective activation of a TNF prodrug by urokinase-type plasminogen activator (uPA) mediated proteolytic processing at the cell surface.
Gerspach J; Németh J; Münkel S; Wajant H; Pfizenmaier K
Cancer Immunol Immunother; 2006 Dec; 55(12):1590-600. PubMed ID: 16636812
[TBL] [Abstract][Full Text] [Related]
13. Cathepsin B-Cleavable Cyclopeptidic Chemotherapeutic Prodrugs.
Herceg V; Bouilloux J; Janikowska K; Allémann E; Lange N
Molecules; 2020 Sep; 25(18):. PubMed ID: 32962018
[TBL] [Abstract][Full Text] [Related]
14. Quantitative modeling of the dynamics and intracellular trafficking of far-red light-activatable prodrugs: implications in stimuli-responsive drug delivery system.
Li M; Thapa P; Rajaputra P; Bio M; Peer CJ; Figg WD; You Y; Woo S
J Pharmacokinet Pharmacodyn; 2017 Dec; 44(6):521-536. PubMed ID: 28913666
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic PEG-coated ROS-sensitive prodrug nanoassemblies for core-shell synergistic chemo-photodynamic therapy.
Sun B; Chen Y; Yu H; Wang C; Zhang X; Zhao H; Chen Q; He Z; Luo C; Sun J
Acta Biomater; 2019 Jul; 92():219-228. PubMed ID: 31078764
[TBL] [Abstract][Full Text] [Related]
16. Uptake and photo-toxicity of Foscan®, Foslip® and Fospeg® in multicellular tumor spheroids.
Gaio E; Scheglmann D; Reddi E; Moret F
J Photochem Photobiol B; 2016 Aug; 161():244-52. PubMed ID: 27285816
[TBL] [Abstract][Full Text] [Related]
17. Pheophorbide-a conjugates with cancer-targeting moieties for targeted photodynamic cancer therapy.
You H; Yoon HE; Jeong PH; Ko H; Yoon JH; Kim YC
Bioorg Med Chem; 2015 Apr; 23(7):1453-62. PubMed ID: 25753328
[TBL] [Abstract][Full Text] [Related]
18. Urokinase plasminogen activator system-targeted delivery of nanobins as a novel ovarian cancer therapy.
Zhang Y; Kenny HA; Swindell EP; Mitra AK; Hankins PL; Ahn RW; Gwin K; Mazar AP; O'Halloran TV; Lengyel E
Mol Cancer Ther; 2013 Dec; 12(12):2628-39. PubMed ID: 24061648
[TBL] [Abstract][Full Text] [Related]
19. Redox-responsive prodrug-like PEGylated macrophotosensitizer nanoparticles for enhanced near-infrared imaging-guided photodynamic therapy.
Ruan Z; Yuan P; Li T; Tian Y; Cheng Q; Yan L
Eur J Pharm Biopharm; 2019 Feb; 135():25-35. PubMed ID: 30550923
[TBL] [Abstract][Full Text] [Related]
20. Membrane transport enhancement of chlorin e6-polyvinylpyrrolidone and its photodynamic efficacy on the chick chorioallantoic model.
Chin WW; Heng PW; Lim PL; Lau WK; Olivo M
J Biophotonics; 2008 Oct; 1(5):395-407. PubMed ID: 19343663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
